NeoPredics AG, based in Switzerland and its subsidiaries NeoPredics AG Germany and NeoPredics USA Inc., are excited to announce the appointment of Mr. Todd Usen as the new Chairman of the Board. This marks a promising new chapter for the company as it continues to expand its influence in maternal and neonatal healthcare.
We would like to express our sincere gratitude to Dr. Volker Pfahlert, who has stepped down after four years of dedicated service. Under his guidance, NeoPredics achieved remarkable progress in predictive analytics and clinical decision support, laying a solid foundation for future advancement.
Mr. Usen comes with a wealth of experience and a solid track record in the MedTech sector, particularly in women’s health. He has shown outstanding leadership in building, restructuring, and scaling organizations—both public and private—with a keen focus on operational and commercial excellence. His skill set includes developing strategic visions, driving product innovation, optimizing logistics, crafting go-to-market strategies, and managing mergers and acquisitions.
With significant achievements such as leading Minerva Surgical through a successful organizational transformation, overseeing the commercialization of Activ Surgical’s groundbreaking AI technology, and driving global growth initiatives at Olympus Medical, Mr. Usen has had a profound impact on the healthcare landscape. His dedication to advancing women’s health resonates deeply with NeoPredics’ mission to deliver innovative solutions that enhance outcomes for mothers and children.
In addition to his new role at NeoPredics, Mr. Usen is currently the President and CEO of Adagio Medical, Inc., a notable innovator in treating cardiac arrhythmias.
As Chairman of the Board for NeoPredics AG, NeoPredics AG Germany, and NeoPredics USA Inc., Mr. Usen will draw on his extensive experience and insights to steer NeoPredics in its mission of creating cutting-edge predictive tools that revolutionize maternal and neonatal care.
Please join us in welcoming Todd Usen to the NeoPredics family as we look forward to a future filled with innovation and meaningful impact.
